Your browser doesn't support javascript.
Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.
Ide, Satoshi; Kutsuna, Satoshi; Yamada, Gen; Hashimoto, Kohei; Abe, Masahiro; Nagi, Minoru; Ujiie, Mugen; Hayakawa, Kayoko; Ohmagari, Norio.
  • Ide S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan. Electronic address: side@hosp.ncgm.go.jp.
  • Kutsuna S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: skutsuna@hosp.ncgm.go.jp.
  • Yamada G; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: gyamada@hosp.ncgm.go.jp.
  • Hashimoto K; Department of Thoracic Surgical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: kohei.hashimoto@jfcr.or.jp.
  • Abe M; Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan. Electronic address: masa-a@niid.go.jp.
  • Nagi M; Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan. Electronic address: nagi@niid.go.jp.
  • Ujiie M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: mgujiie@hosp.ncgm.go.jp.
  • Hayakawa K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: khayakawa@hosp.ncgm.go.jp.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: nohmagari@hosp.ncgm.go.jp.
J Infect Chemother ; 27(11): 1658-1661, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1281463
ABSTRACT
Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also been suggested. Moreover, it is assumed that the number of travelers and endemic mycoses has decreased with the recent coronavirus disease 2019 epidemic. However, clinicians should carefully consider the differential diagnosis of histoplasmosis for travelers traveling to endemic areas. In this case report, we describe an immunocompetent Japanese woman who developed histoplasmosis due to a history of travel to an endemic country. Our case report suggests that clinicians should not exclude histoplasmosis from the differential diagnosis even in the absence of risk features such as activities or immunodeficiencies during travel.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Histoplasmosis Type of study: Case report / Diagnostic study / Prognostic study Limits: Adult / Female / Humans Country/Region as subject: South America / Asia Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Histoplasmosis Type of study: Case report / Diagnostic study / Prognostic study Limits: Adult / Female / Humans Country/Region as subject: South America / Asia Language: English Journal: J Infect Chemother Journal subject: Microbiology / Drug Therapy Year: 2021 Document Type: Article